Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Sunday, July 20, 2025.
SAB Biotherapeutics, Inc. (NASDAQ:SABS)
Long-Term Uptrend (+90) - SABS is in a strong uptrend that is likely to continue. While SABS is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid SABS?
MarketClub looks at technical strength and momentum to determine if the timing is right for SABS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for SABS
The long-term trend has been UP since Jul 8th, 2025 at 2.15
The intermediate-term trend has been UP since Jul 7th, 2025 at 1.87
The short-term trend has been UP since Jul 16th, 2025 at 2.84
Smart Scan Analysis for SABS
Based on our trend formula, SABS is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 2.8100 | 2.8550 | 2.6901 | 2.8000 | -0.0400 |
| Prev. Close | Volume | Bid | Ask | Time |
| 2.5700 | 8653 | 2025-07-18 11:41:48 |
| 52wk High | 5.01 | 52wk High Date | 2024-12-09 |
| 52wk Low | 1 | 52wk Low Date | 2025-04-04 |
| Average Volume | 37,334 | Shares Outstanding | 9,292 |
| Assets | 38,120,062M | Liabilities | 16,712,563M |
| P/E Ratio | -1.03510000 |